Devendra Mishra, The Co-Founder of BSMA and the former adjunct professor of Supply Chain Management at the Graziadio School of Business has been the president LIVE Entertainment, VCL-Carolco (Germany), Lieberman Enterprises and Technicolor, Strawberries Records and Tapes, and CEO of VSA (a subsidiary of International Multifoods). At RCA Records as the Vice President of worldwide operations. He is renowned as an international expert on supply chain management.

Over 25 years experience in Supply Chain leadership roles in consumer products and biotech companies. Specialize in E2E supply chain strategy, S&OP, inventory management, and system enabled process improvement
2015 – present, VP Global Supply Chain, illumina
2011 – 2015: VP Global Supply Chain for Bayer Healthcare Biotech Division
2009-2011: Sr. Director Global Supply Chain for Bayer Healthcare Medical Devices Division
2004 – 2009: Sr. Director Global Supply Chain Planning for The Clorox Company
2002 – 2004: Sr. Director S&OP/Supply Planning for Levi-Strauss & Co.
1997– 2002: Sr. Director Deloitte Consulting
MBA – Harvard Business School, 1997
1988 – 1995: Various engineering, manufacturing, and supply chain roles for The Clorox Company
B.S. Chemical Engr. – Cornell University, 1988

Strategic Sourcing

Horacio Enriquez, is a dynamic and innovative Supply Chain and Quality Operations executive with 25 years of semiconductor, telecommunications, consumer electronics, clinical diagnostics, biopharmaceutical, and integrated facilities management industry experience, including roles of progressive and increased leadership in Plan, Source, Make, Deliver business streams, supplier quality, risk, & compliance, and business systems integration organizations.

A graduate of Santa Clara University (BS Mechanical Engineering & MS Engineering Management), Horacio is CEO and Founder of Mission City Consulting, which provides end to end supply chain and quality operations consulting, education, and advocacy in private industry, higher learning, and government institutions. Besides being a Principal and faculty member of the Biotech Supply Chain Academy, Horacio is a UC Davis Graduate School of Management Lecturer (2019-2020 Academic Year) and Adjunct Professor (2020-2021 Academic Year).

Horacio also volunteers with the Bio Supply Management Alliance, American Association of Precision Medicine, and the California Life Sciences Association, where he has served in various roles including Chairman of the Council of Suppliers and Service Providers, Executive Education Program Founding Member, AAPM ACT Supply Chain Committee Chair, and Conference Moderator, Speaker, and Panelist (US, Belgium, Switzerland).

Dr. Khalid Shah is the Vice President and Head of Pharmaceutical Operations and Supply Chain at Exelixis. His CMC and pharmaceutical operations organization includes clinical and commercial Drug substance and Drug product manufacturing, packaging and labelling to support Exelixis marketed products. He teams have successfully taken products through the development cycle, process optimization, process validation and subsequent product launches. Recently, he managed and oversaw development, optimization, validation, and launch of COMETRIQ® which was approved by the FDA in 2012 and in the EU following approval by the European Commission in 2014. Subsequent to that, his teams successfully developed and launched CABOMETYX® in the US and EU 2016.
Dr. Shah’s clinical supplies organization supports packaging, labeling and distribution of all Exelixis ongoing and partnered clinical trials across the multiple oncology clinical study portfolio. His team has successfully provided investigational products to more than 5000 patients over the last several years

Dr. Randy V. Bradley, an Associate Professor of Information Systems and Supply Chain Management and a Haslam Family Faculty Research Scholar in the Haslam College of Business at The University of Tennessee, has been appointed as the Executive Vice President of Digital Transformation in Life Sciences, BSMA. Dr. Bradley is also the co-founder and Chief Information Officer for Q-Leap Health Inc, which develops innovative, collaborative solutions for healthcare professionals and practitioners to promote team science in an effort to address healthcare disparities and health inequities. Additionally, he is a co-founder and Director of the 501(C)(3) designated Consortium on Disparities in Urologic Conditions, which is in the process of launching the Scientific Consortium on PCa Education (SCOPE) Registry.

He currently serves on the Board of Directors of the Supply Chain Advancement Network in Health (SCAN Health) and the Advisory Council of World Health Innovation Network (WIN), based in Windsor, Ontario, Canada. He also serves on the Advisory Board of Negometrix, a Netherlands-based company with a US subsidiary that works with private and public organizations across many sectors to digitize their procurement processes.

Dr. Randy V. Bradley holds a Ph.D. in Management of Information Technology (IT) and Innovation, an M.S. in Management Information Systems, and a B.S. in Computer Engineering, all from Auburn University. He is a preeminent visionary, global thought leader, and highly sought-after speaker as a supply chain and IT strategist and researcher. In addition to his leadership roles with AHRMM, HIMSS, Negometrix, SCAN Health, and WIN, Dr. Bradley has contributed his expertise to many leading domestic and international associations, including the China Association of Pharmaceutical Commerce, Health Industry Distributors Association (HIDA), Healthcare Supply Chain Network (HSCN), Healthcare Distribution Alliance (HDA), HealthPRO, Capstone Health Alliance, Material Handling Institute (MHI), National Institute of Governmental Purchasing (NIGP), National Association of Educational Procurement (NAEP), Association for Information Systems (AIS), Council of Supply Chain Management Professionals (CSCMP) and Decision Sciences Institute (DSI). Dr. Bradley has been recognized for his excellence in teaching and promoting diversity and inclusion in academia, including the 2019 Richard Sanders Faculty Leadership Award, National Association of Black Accountants 2017 National Achievement in Education Award and designation as a HIMSS Fellow.

He has nearly 25 years of industry experience of IT transformation in the supply chain, he has consulted for and advised federal and state organizations and multinational companies. His insights have been chronicled in Bloomberg Law, Thrive Global, Business Wire, MarketWatch, SupplyChain247, IoT World Today, Supply Chain Dive, TechTarget, Supply Chain Quarterly, DC Velocity, MHI Solutions, Healthcare Purchasing News, and HealthPRO News, among others.

Gary Workman is the Vice President of Global Quality and Compliance at Illumina. He has served as a transformation leader while instilling the disciplines to enable Illumina’s long-term success to improve the human condition through the power of the genome.
Gary has more than 30 years of professional experience specializing in Quality and the application of lean manufacturing and quality management systems in both high volume production and rapidly growing new technology start-ups. The core of Gary’s professional experience was at Toyota where he specialized in the application of the principles of the Toyota Production System to achieve the highest levels of customer satisfaction and productivity. 
Gary is passionate about the human element in business constantly seeking to improve organizational efficiency and a culture of continuous improvement.
In his spare time, Gary enjoys time with his family. He is an avid open water swimmer.

Joel Glende is currently the Chairperson of the Transportation and Logistics Steering Committee to advance best practices in product protection, monitoring & adoption of disruptive technologies in Life Science Logistics.

Joel retired from Abbott Laboratories in 2016 after more than 38 years of service, with the last 19 years in supply chain and 15 years prior to that in packaging engineering. He has been recognized at Abbott and in the Life Sciences Industry for his leadership in leading significant efforts for the corporation in Air, Ocean and other logistics efforts resulting in mutual gain strategic partnerships across the shipper and service industry. Joel holds a Bachelor’s degree from the University of Texas, Austin.

Paul Anderson, Senior Director of Clinical Operations at Illumina, is responsible for ensuring operational readiness for Illumina’s rapidly expanding global clinical business.  He was formerly Head of Global Supply Chain and Head of Operations Strategy at Thermo Fisher Scientific.  Formerly at Life Technologies, Mr. Anderson was VP, Strategic Operations and VP, Global Procurement & Planning.  He was also an executive leader at Applied Biosystems and led the global procurement, sales & operations planning, global distribution, program management and business systems organizations. Mr. Anderson also held numerous leadership positions in supply chain management and manufacturing at Perkin-Elmer Corporation and General Electric. Mr. Anderson is a graduate of the GE Manufacturing Management Program and has a Bachelor of Science, Magna Cum Laude, in Industrial Engineering, from Oregon State University and an MBA from Harvard Business School. He previously served on the board of directors of BIOCOM Purchasing Group.

With more than 25 years of pharmaceutical supply chain experience, Paul Furgal helps clients devise and implement successful commercial solutions. Throughout his career, he has acquired proficiency in specialty pharmacy and distribution contracting, cell and gene therapies, reimbursement hub development, market access, and biologic product launches. Today, he is able to provide a unique insider perspective and offer creative solutions to the supply chain challenges facing new products, such as cell and gene therapies.

Prior to joining Archbow, Paul worked at McKesson Specialty Health for 16 years. During that time, he worked in trade relations, built McKesson’s 3PL sevice offering, led business development, and was responsible for all strategic, commercial, and operational aspects of Supply Chain Solutions/Managed Distribution. He also created and led McKesson’s go-to-market cell and gene therapy solution for manufacturers. Before McKesson, Paul held a variety of roles of increasing responsibility with EMD Serono and Abbvie such as primary care sales representative, hospital sales representative, regional sales manager, branded product manager, managed care marketing, managed care account management, national trade director, and business unit director.

Paul has Bachelor degrees from the University of Windsor and Saint Bonaventure University. He lives in Southlake, TX with his family, a wife and four children (all sons!), who make life so full that he has time for little else.

Dr. Bain has an extraordinary, diverse background in regulatory compliance in a broad range of FDA-regulated industries including medical device, pharmaceutical, and biotechnology industries, and as an FDA Investigator. She has held various senior-level management positions in Quality Control/Assurance and Regulatory Affairs with Baxter Healthcare, Grifols, Medegen, Inc., Peregrine Corporation, and Watson Pharmaceuticals.
She is the former Professor of Practice and Program Director for Clinical, Regulatory and Quality at Keck Graduate Institute (KGI) and Adjunct Professor of Practice and Concentration Coordinator for Clinical and Regulatory in KGI’s School of Pharmacy. She is an accomplished quality, compliance and regulatory professional with experience in medical device, pharmaceutical, and biotechnology industries.
Her educational background includes a Doctorate of Regulatory Science (DRSc), a Master of Science in Regulatory Science (MSc) from the University of Southern California (USC) and a Bachelor of Science in Biological Science from Cal Poly, Pomona.

Ricky joined Genentech / Roche as a Digital Transformation Lead and is a key contributor to the global transformation of process, technology, culture, and user experience across the supply chain. He has led large digital transformation initiatives for numerous Fortune 500 companies across pharma, financial services, CPG, automotive and education industries.
 
Ricky is passionate about putting ‘digital’ into action through cultural, technology, and strategic transformation. He has led the design of new consumer experiences, the integration of digital methodologies across corporate operating models, and the implementation of a number of innovative technologies across the supply chain. He has held leadership roles at various digital and innovation consultancies and has over 10 years experience in the space. He is currently focused on exploring and implementing technologies to drive new supply chain models and capabilities specific to personalized healthcare. 

Mr. Rosen is Senior Vice President of Commercial Strategy & Public Policy with responsibility for leading commercial strategy efforts instrumental to ensuring future patient access to Novavax vaccines. During the COVID pandemic, he led the negotiations with Operation Warp Speed, the Department of Defense and the Coalition for Epidemic Preparedness Innovation (CEPI), leading to $2 billion in grants for the organization’s vaccine development efforts.  Mr. Rosen joined Novavax in 2015 as vice president of market access and policy and was named vice president of commercial strategy in June 2018.

He came to Novavax with more than 20 years of industry, legal, and patient advocacy experience with the vast majority engaged in government affairs, advocacy, reimbursement, and policy work. Prior to Novavax, Mr. Rosen was most recently the chief policy, advocacy and patient access officer for the Leukemia & Lymphoma Society, where he oversaw all legislative and regulatory efforts and the delivery of patient services nationwide; prior to that, he developed and ran the government affairs, policy, and alliance development functions for MedImmune. Mr. Rosen currently serves as chair of the board of directors of Learning Undefeated, a nonprofit that provides STEM education and workforce development to underserved communities. Mr. Rosen received a bachelor of arts degree in history and psychology from Tufts University and a juris doctorate from Hofstra University School of Law.

Former AMR/Gartner analyst, Roddy Martin brings more than 36 years of experience in engineering, manufacturing, supply chain, technology, sales and marketing, strategy and operations consulting to his role. Martin also has Executive Leadership experience from South African Breweries. He works closely with senior executives from global life sciences, CPG and Hi-Tech companies and has experience with several global clients in End-to-End Supply Chain Strategy, Digital Transformation, Segmentation, and Change Leadership as part of their business transformation initiatives. 
Martin has worked as SVP for SAB Miller, AMR Research/ Gartner, Accenture as a partner, CCI, Oracle, Infor, and Kinaxis. He has also worked with leading global companies on elements of end-to-end Business Operating Model Transformation; P & G,  J & J, SAB Miller, General Mills, Biogen, Schneider, Nestle, and many others. 
Today, Martin is an independent thought leader, coach, mentor, and consultant as Subject Matter Expert for numerous large and smaller International Management Consultants, Vendors and Manufacturers.
 

Albert Cooksey is Senior Vice President of Client Relations for ICS. Mr. Cooksey supports pharmaceutical manufacturers launching commercial medications, including cell and gene therapies, by providing consultation throughout the sales process. He manages all aspects of business development activities to ensure RFPs meet the needs of each pharmaceutical manufacturer, while also working with existing clients on logistics solutions and new product introductions into the ICS 3PL support model. 

 Mr. Cooksey has played an instrumental role in supporting the launch of many new pharmaceutical products, and most recently is leading the company’s Cell and Gene Therapy offering through our integrated commercialization services.

 Mr. Cooksey holds a Bachelor of Science in Agri-Economics from Texas A&M University, where he graduated in 1996.

M. Dave Malenfant is currently Executive Vice President of Industry Liaison and Talent Development for the BSMA (Biotech Supply Management Alliance). He also serves as Director, Outreach and Partnerships as well as oversees the Advisory Board for the Center for Supply Chain Innovation at Texas Christian University. Dave is responsible for driving Industry relations in the Biotech, Biopharma Supply Chain for the BSMA. Prior to this appointment, Dave served on the Advisory Board for the BSMA from its inception. With a passion for talent development and career planning, Dave has helped both the BSMA and the Center for Supply Chain Innovation drive Young Professional career development and mentoring programs for students.

Prior to joining the BSMA and TCU, Dave spent over 30 years in a variety of industry roles. As an entrepreneur, Dave was Co-founder and President of Signature Consultants, Inc., (1973) a business, finance, and economic consulting firm that he ultimately sold in 1993. He created and operated a variety of other businesses that are still profitable in Canada today.

In 1993, Dave joined Alcon Laboratories where he steadily advanced through leadership roles such as Purchasing Manager, Materials Operation Manager, and Global Supply Chain Director before becoming the Vice President of Global Supply Chain in 2005. In this role, Dave provided strategic direction for the company’s Global Supply Chain initiatives and created global centers of excellence for Purchasing, Distribution, Transportation, Customer Service, Sales and Operations Management, Data Management, Graphic Design and Artwork Development, and Product Launches. Dave retired from Alcon in 2014.

Dave is recognized for the creative development of standardized systems and business processes, and for developing enabling technology throughout the entire supply chain. During his career, Dave has implemented over 30 different computer systems – WMS, ERP, Finite Scheduling, Product Launch, and Order Entry, among others. Dave is past Chairman of the Supply Chain Council and past member of the Executive Committee of NASSTRAC.

Given his vast knowledge of the end-to-end, integrated supply chain, Dave is a frequent speaker on Global Supply Chain Trends. He has consistently demonstrated his passion for Supply Chain management, developing talent, and the need to advance Supply Chain theory and innovation throughout a variety of industries.

Joel earned an MBA from Pepperdine University and a BS degree in logistics management from the University of Southern California, where he also served as an adjunct professor. Since 2006, Joel has been in academia full time, first at Lehigh University in Pennsylvania, where he served as Managing Director for the Center for Value Chain Research; and since 2011 at the University of San Diego, where he serves as Managing Director for the Supply Chain Management Institute and is a Professor of Practice in supply chain management.

Joel is a past Board Chair of the Council of Supply Chain Management Professionals (CSCMP) and in 2009 received their highest honor – the Distinguished Service Award – an award given to only one professional each year based on a career dedicated to the profession. In 2002, Joel led the effort to provide a comprehensive definition of supply chain management, an effort that enabled the Council of Logistics Management (CLM) to change its name to the Council of Supply Chain Management Professionals (CSCMP) in 2004. Joel also received the Professional Achievement Award from Logistics Management magazine; was recognized as one of the Top 20 Logistics Executives by CLO magazine and the Logistics & Supply Chain Forum; was honored as a Thought Leader by Supply Chain Quarterly and DC Velocity magazines; is an inaugural member of CSCMP’s Circle of Excellence; and is in the CSCMP Hall of Fame.

Company & Tenure: Illumina Inc, HQ, San Diego, 3 ½ yrs

Professional Background: 20+ years expertise ensuring
business continuity, driving continuous improvement,
developing teams, and implementing solutions in Supply
Chain, Quality Management, Engineering, & Logistics

Prior Industries & Companies: Life Science, Energy,
Med-Device Industries at Applied Biosystems, Bloom Energy,
Accuray, & Illumina

Fun Facts: I enjoy golf, road biking, snow skiing, working out,
& kayaking., Creative in the Kitchen, Do-it-yourselfer

International biotech executive with MBA from Wharton Business School with over 20 years of success at fundraising, architecting innovative corporate/product strategies and leading high-performance teams. Adept at building worldwide relationships with investors, investment banks, NGO/GOs, strategic partners, and shareholders. A passionate visionary with a clear sense of purpose and urgency when faced with diverse situational challenges including the launch of emerging technologies across various industries with leading firms such as Mucosis B.V., Novavax, Microsoft, and Comcast.

Current roles include:

COVID-19 Vaccine Response including Sr Consultant Business Development, CEPI – cepi.net – manufacturing scale up and scale out, vaccine development deals, etc.

CBO and Advisor for various early start ups including: StraxImm, Avaliv, and others.

Conway is past national chair of the Association for Healthcare Resource and Materials Management (AHRMM), and serves on the boards of the Strategic Marketplace Initiative (SMI) and the Bellwether League, the GS1 Global Healthcare Leadership Team, the expert advisory council for the Supply Chain Advancement Network in Health, and the healthcare advisory board for CAPS Research.

She is a co-author of the global leadership book, Leading from the Edge, a contributing author to eBusiness in Healthcare, and a monthly columnist on “Standard Practices” in healthcare.

Conway holds a Masters in the Science of Healthcare Delivery from Arizona State University and a bachelors degree from The Colorado College.

He is a member of the Forbes Technology Council, speaker for various pharmaceutical conferences and has successfully developed cold chain transport validation data for more than 75 new drug product filings and other regulatory interactions with multiple regulatory agencies around the globe in the last 3 years alone.

Peter is an Abbott Director of International Distribution responsible for providing customers and Abbott affiliates with Life Science Products worldwide.

His team of 260 employees support the Import, Export, and distribution for the EU and into more than 160 Countries across the world.

From Abbott’s European Distribution center he supports 4 Billions of sales that contains inventory from 5of it’s company’s Divisions, constantly over

350 Mio $ inventory value. He is responsible for $25 Million in Operating Expense including more than $12 Million in direct Freight Spending annually.

He is a veteran of Abbott with more than 31 years of service and Holds a Bachelor’s degree in Economics from Mainz University, Germany and has

A Professional Certification in Procurement and Logistics (CCI). 

with the supply chain and operations/quality environment. Experience gained in the project based/development role and in the operational role within the supply chain.

He has a proven track record, having worked in both commercial and executive leadership roles with internationally well-known service providers specialized in logistic and supply chain and contract logistic solutions for the pharma industry.

Marrie has joined SkyCell in January 2018 and is based in Zurich, Switzerland.